Table 3. Relationship between EMAP-II expression and clinico-pathological features.

Variables	Total	1–25%	26–50%	51–75%	76–100%	P-valuea
Age tertile						NSb
<61	20	3	2	4	11
61.1–71.9	22	1	6	5	10
⩾72	30	3	6	7	14
Type						NS
Nonmucinous	66	7	13	15	31
Mucinous	6		1	1	4
Site						NS
Left colon	3			2	1
Caecum	17	2	5	3	7
Right colon	4				4
Transverse, splenic	3				3
Rectum	24	3	3	6	12
Rectum-sigmoid	8		2	1	5
Sigmoid	13	2	4	6	1
Size median						NS
<Median	28	5	4	5	14
⩾Median	44	2	10	12	20
Dukes' stage						<0.01
A	18	2	4	3	9
B	32	4	7	8	13
C	22	1	3	5	13
Differentiation						NS
Moderate	4	1			3
Well	62	6	12	15	29
Poor	6		2	1	3
Metastasis						0.05
Primary	72	7	14	16	35
Secondary	13	1	1	4	7
Lymphatic metastasis						0.05
At DXc	24	1	4	6	13
During FUd	2		2
No metastasis	46	6	10	8	22
Vascular metastasis						0.01
<Median	37	5	6	9	17
⩾Median	35	2	8	7	18
Lymph node metastasis						<0.01
No	43	6	9	8	20
Yes	29	1	5	8	15
Death						0.03
No	28	3	5	8	12
Yes	44	4	9	8	23
Recurrence						0.01
Yes	25	1	5	7	12
No	42	6	9	7	20
NA	5			2	3
Gender						NS
Male	42	3	10	7	22
Female	30	4	4	9	13

^aP-value by multivariate regression analysis.

^bNot significant.

^cAt Dukes' C.

^dNodal recurrence.